How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Tissue Level Implant Market
- By Implant Material: Titanium, Zirconia, Titanium Alloy, Ceramic
- By Implant Design: Single-piece Implant, Two-piece Implant, Conical Connection Implant, External Hex Connection Implant
- By Surface Treatment: Sandblasted Acid-Etched (SLA), Plasma Sprayed, Anodized Surface, Hydroxyapatite Coating
- By End User: Dental Clinics, Hospitals, Specialized Dental Implant Centers, Oral Surgery Centers
- By Application: Single Tooth Replacement, Multiple Teeth Replacement, Full Arch Restoration, Immediate Implant Placement
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Titanium leads By Implant Material at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 293 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.176 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.184 →
Full report · locked preview
Everything inside the Tissue Level Implant Market report
A complete, evidence-based study - 12 chapters and 123 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Implant Material 4
Implant Design 4
Surface Treatment 4
End User 4
Application 4
Companies profiled
Straumann Group
Dentsply Sirona
Nobel Biocare (Danaher Corporation)
Zimmer Biomet
Osstem Implant
BioHorizons
MIS Implants Technologies
Hiossen Implant
Megagen
Dentium
Neodent (Straumann Group)
Bicon Dental Implants
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Straumann Group
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Dentsply Sirona
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Nobel Biocare (Danaher Corporation)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Zimmer Biomet
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Osstem Implant
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →BioHorizons
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →MIS Implants Technologies
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Hiossen Implant
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Megagen
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Dentium
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Neodent (Straumann Group)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Bicon Dental Implants
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Thommen Medical
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Ankylos (Dentsply Sirona)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Southern Implants
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,027M by 2033 · 4.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Titanium47.7
- Zirconia14.9
- Titanium Alloy16.4
- Ceramic21.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$455.0M → $669.7M · 4.9%
Europe$317.1M → $434.1M · 4.0%
Asia Pacific$289.5M → $470.5M · 6.3%
Latin America$179.2M → $240.2M · 3.7%
Middle East and Africa$137.9M → $222.8M · 6.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.882026
4.912027
4.922028
4.932029
4.932030
4.962031
4.962032
4.972033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Straumann Group19.2
- Dentsply Sirona13.0
- Nobel Biocare (Danaher Corporation)5.2
- Zimmer Biomet5.4
- Osstem Implant17.1
- BioHorizons12.1
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Implant Material28.4%
Implant Design16.7%
Surface Treatment13.3%
End User17.9%
Application23.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.9
- Europe21.3
- Asia Pacific23.1
- Latin America11.8
- Middle East and Africa10.9
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Straumann Group | 99 | 89 | 81 | 97 | 81 | 95 | 90 |
| Dentsply Sirona | 70 | 75 | 71 | 74 | 76 | 90 | 76 |
| Nobel Biocare (Danaher Corporation) | 68 | 76 | 66 | 64 | 66 | 65 | 68 |
| Zimmer Biomet | 75 | 81 | 77 | 81 | 63 | 81 | 76 |
| Osstem Implant | 61 | 58 | 66 | 61 | 64 | 71 | 64 |
| BioHorizons | 62 | 47 | 51 | 65 | 71 | 61 | 60 |
| MIS Implants Technologies | 47 | 56 | 54 | 43 | 42 | 62 | 51 |
| Hiossen Implant | 44 | 59 | 47 | 45 | 57 | 39 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Straumann Group
- Dentsply Sirona
- Nobel Biocare (Danaher Corporation)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Straumann Group | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Dentsply Sirona | ◐ | ◐ | ✓ | ◐ | ◐ | ✓ |
| Nobel Biocare (Danaher Corporation) | − | ◐ | − | ✓ | − | ◐ |
| Zimmer Biomet | ✓ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Osstem Implant | − | ◐ | ✓ | ◐ | − | ✓ |
| BioHorizons | − | − | − | − | ◐ | − |
| MIS Implants Technologies | ◐ | − | − | − | − | − |
| Hiossen Implant | − | ◐ | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Straumann Group90
2Dentsply Sirona76
3Zimmer Biomet76
4Nobel Biocare (Danaher Corporation)68
5Osstem Implant64
6BioHorizons60
7MIS Implants Technologies51
8Hiossen Implant49
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Straumann Group
Challenger3
Strong scale, closing on the leaders.
Dentsply SironaNobel Biocare (Danaher Corporation)Zimmer Biomet
Contender2
Focused players with pockets of strength.
Osstem ImplantBioHorizons
Niche2
Specialists in a single segment or region.
MIS Implants TechnologiesHiossen Implant
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Implant Material in North America, then scale across Tissue Level Implant Market — a $603M beachhead inside a $8.80B market.
Beachhead (SOM)$603Mobtainable near-term
Serviceable (SAM)$3.37Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Titanium
Best fit — highest urgency & budget in Implant Material.
Economic buyer80 fit
Zirconia
Strong fit — clear ROI and a fast path to value.
End user64 fit
Titanium Alloy
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Implant Material in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Implant Design & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Surface Treatment
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel29%
Digital / self-serve19%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Implant Material leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Tissue Level Implant Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified25%
Evaluation14%
Closed-won7%
$22.0KCAC
$121KLTV
5.5:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Tissue Level Implant Market is a durable-growth opportunity — $5.91B by 2033, compounding at 7.2%.
TAM · 2025$3.40Btoday
TAM · 2033$5.91Bforecast
CAGR7.2%2027–2033
Cumulative$41.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.91BTotal addressable market
SAM$2.45BServiceable available market
SOM$513MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.2% CAGR
Demand compounds through 2033, outpacing GDP across Implant Material.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Implant Material moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.91BLarge & growingTAM by 2033 at 7.2% CAGR
$2.45BServiceable nowreachable with today’s model
$513MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.61BBear4.7% CAGR
$5.91BBase7.2% CAGR
$7.57BBull9.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Implant Design optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Tissue Level Implant Market — a $3.88B market by 2033. Plan: grow share from 8.2% to 15.1%.
Market size · 2033$3.88Btotal addressable
Market CAGR6.6%2027–2033
Target share15.1%from 8.2% today
Revenue ambition$585Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.2% | 15.1% | On track |
| Revenue | $286M | $585M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 28.8% | 43.9% | Ahead |
| Customer retention | 90.3% | 94.8% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Implant Material
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Implant Design capability
A defensible second engine — invest in Implant Design to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Implant Material share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Implant Design
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $78M capacity & capability investment
- Greenlight bolt-on M&A in Implant Design
- Authorise North America expansion plan
- Fund R&D program for Implant Material leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Tissue Level Implant Market conversation — a $6.26B market you can size, segment and defend in minutes.
Market size · 2033$6.26Btotal opportunity
Growth11.5%CAGR to 2033
Addressable buyers1,122+accounts in scope
Typical ROI7.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Implant Material
Goal Grow share in Implant Material
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.5×return on cost, year one
< 4 mopayback period
$85K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Straumann GroupDentsply SironaNobel Biocare (Danaher Corporation)Zimmer BiometOsstem ImplantBioHorizonsMIS Implants TechnologiesHiossen Implant+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Tissue Level Implant Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Tissue Level Implant Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) ELISA Kit Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportTissue Imaging Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportTissue Homogenizers Market
Market size, share, segmentation and regional forecast.
$543M market · 2025 base year
View reportTissue Heart Valves Device Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportTissue Freeze Spray Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportTissue Flotation Water Bath and Slide Dryer Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportTissue Flotation Bath Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportTissue Floation Bath Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportTissue Factor Pathway Inhibitor (TFPI) ELISA Kit Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportTissue Extenders Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportTissue Expansion Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportTissue Equipment Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.